Living-donor kidney transplant

Clinical trials for Living-donor kidney transplant explained in plain language.

Never miss a new study

Get alerted when new Living-donor kidney transplant trials appear

Sign up with your email to follow new studies for Living-donor kidney transplant, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a Two-Pronged immune attack stop kidney transplant rejection?

Disease control Completed

Researchers are testing whether a combination of drugs, including lulizumab pegol and tocilizumab, can safely prevent organ rejection in people who receive a kidney from a living donor. The study also uses standard anti-rejection medicines like rabbit antithymocyte globulin, meth…

Matched conditions: LIVING-DONOR KIDNEY TRANSPLANT

Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Sep 26, 2026 00:00 UTC

Living-donor kidney transplant

Get alerted when new Living-donor kidney transplant trials appear

Can a Two-Pronged immune attack stop kidney transplant rejection?